Your browser doesn't support javascript.
loading
Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study.
Aiano, Felicity; Ireland, Georgina; Baawuah, Frances; Beckmann, Joanne; Okike, Ifeanyichukwu O; Ahmad, Shazaad; Garstang, Joanna; Brent, Andrew J; Brent, Bernadette; Borrow, Ray; Linley, Ezra; Ho, Sammy; Carr, Christine; Zambon, Maria; Poh, John; Warrener, Lenesha; Amirthalingam, Gayatri; Brown, Kevin E; Ramsay, Mary E; Hoschler, Katja; Ladhani, Shamez N.
Afiliación
  • Aiano F; From the Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency.
  • Ireland G; From the Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency.
  • Baawuah F; From the Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency.
  • Beckmann J; East London NHS Foundation Trust, London.
  • Okike IO; From the Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency.
  • Ahmad S; University Hospitals of Derby and Burton NHS Foundation Trust, Derby.
  • Garstang J; Manchester University NHS Foundation Trust, Manchester.
  • Brent AJ; Birmingham Community Healthcare NHS Trust, Aston.
  • Brent B; Nuffield Department of Medicine, Oxford University Hospitals NHS Foundation Trust.
  • Borrow R; University of Oxford, Oxford.
  • Linley E; Nuffield Department of Medicine, Oxford University Hospitals NHS Foundation Trust.
  • Ho S; UK Health Security Agency, Manchester Royal Infirmary, Manchester.
  • Carr C; UK Health Security Agency, Manchester Royal Infirmary, Manchester.
  • Zambon M; From the Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency.
  • Poh J; From the Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency.
  • Warrener L; From the Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency.
  • Amirthalingam G; From the Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency.
  • Brown KE; From the Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency.
  • Ramsay ME; From the Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency.
  • Hoschler K; From the Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency.
  • Ladhani SN; From the Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency.
Pediatr Infect Dis J ; 42(6): 496-502, 2023 06 01.
Article en En | MEDLINE | ID: mdl-36916856
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies Límite: Adolescent / Child / Humans Idioma: En Revista: Pediatr Infect Dis J Asunto de la revista: DOENCAS TRANSMISSIVEIS / PEDIATRIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies Límite: Adolescent / Child / Humans Idioma: En Revista: Pediatr Infect Dis J Asunto de la revista: DOENCAS TRANSMISSIVEIS / PEDIATRIA Año: 2023 Tipo del documento: Article